Clinical trial
Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder
NCT00215137 · Duke University, Other · Completed
Key facts
| NCT number | NCT00215137 |
|---|---|
| Title | Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder |
| Official title | Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder |
| Lead sponsor | Duke University, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | OCD |
| Intervention type | Drug |
| Interventions | escitalopram, Placebo ( sugar pill) |
| Enrollment | 14 |
| Start date | Oct 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 23, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: